Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ATHA is expected to report earnings to fall 4.35% to -21 cents per share on August 18
Q2'25
Est.
$-0.22
Q1'25
Missed
by $0.05
Q4'24
Est.
$-0.38
Q3'24
Missed
by $0.05
Q2'24
Beat
by $0.04
The last earnings report on May 09 showed earnings per share of -23 cents, missing the estimate of -18 cents. With 41.89K shares outstanding, the current market capitalization sits at 14.45M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATHA showed earnings on May 09, 2025. You can read more about the earnings report here.